Drug Profile


Alternative Names: BAY 389456; Levitra; Nuviva; Staxyn; Vardenafil ODT; Vardenafil orodispersible tablet; Vivanza

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bayer
  • Class Erectile dysfunction therapies; Imidazoles; Piperazines; Small molecules; Sulfones; Triazines
  • Mechanism of Action Type 5 cyclic nucleotide phosphodiesterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Erectile dysfunction
  • No development reported Overactive bladder

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 29 Aug 2011 Registered for Erectile dysfunction in Canada (Buccal)
  • 22 Mar 2011 Launched for Erectile dysfunction in United Kingdom (Buccal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top